Phenotyping of COPD with MRI in comparison to same-day CT in a multi-centre trial.
Chronic obstructive pulmonary disease
Computed tomography
Magnetic resonance imaging
Pulmonary emphysema
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
12 Feb 2024
12 Feb 2024
Historique:
received:
10
09
2023
accepted:
24
12
2023
revised:
07
12
2023
medline:
12
2
2024
pubmed:
12
2
2024
entrez:
12
2
2024
Statut:
aheadofprint
Résumé
A prospective, multi-centre study to evaluate concordance of morphologic lung MRI and CT in chronic obstructive pulmonary disease (COPD) phenotyping for airway disease and emphysema. A total of 601 participants with COPD from 15 sites underwent same-day morpho-functional chest MRI and paired inspiratory-expiratory CT. Two readers systematically scored bronchial wall thickening, bronchiectasis, centrilobular nodules, air trapping and lung parenchyma defects in each lung lobe and determined COPD phenotype. A third reader acted as adjudicator to establish consensus. Inter-modality and inter-reader agreement were assessed using Cohen's kappa (im-κ and ir-κ). The mean combined MRI score for bronchiectasis/bronchial wall thickening was 4.5/12 (CT scores, 2.2/12 for bronchiectasis and 6/12 for bronchial wall thickening; im-κ, 0.04-0.3). Expiratory right/left bronchial collapse was observed in 51 and 47/583 on MRI (62 and 57/599 on CT; im-κ, 0.49-0.52). Markers of small airways disease on MRI were 0.15/12 for centrilobular nodules (CT, 0.34/12), 0.94/12 for air trapping (CT, 0.9/12) and 7.6/12 for perfusion deficits (CT, 0.37/12 for mosaic attenuation; im-κ, 0.1-0.41). The mean lung defect score on MRI was 1.3/12 (CT emphysema score, 5.8/24; im-κ, 0.18-0.26). Airway-/emphysema/mixed COPD phenotypes were assigned in 370, 218 and 10 of 583 cases on MRI (347, 218 and 34 of 599 cases on CT; im-κ, 0.63). For all examined features, inter-reader agreement on MRI was lower than on CT. Concordance of MRI and CT for phenotyping of COPD in a multi-centre setting was substantial with variable inter-modality and inter-reader concordance for single diagnostic key features. MRI of lung morphology may well serve as a radiation-free imaging modality for COPD in scientific and clinical settings, given that its potential and limitations as shown here are carefully considered. • In a multi-centre setting, MRI and CT showed substantial concordance for phenotyping of COPD (airway-/emphysema-/mixed-type). • Individual features of COPD demonstrated variable inter-modality concordance with features of pulmonary hypertension showing the highest and bronchiectasis showing the lowest concordance. • For all single features of COPD, inter-reader agreement was lower on MRI than on CT.
Identifiants
pubmed: 38345607
doi: 10.1007/s00330-024-10610-0
pii: 10.1007/s00330-024-10610-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GI0884
Informations de copyright
© 2024. The Author(s).
Références
Vos T, Lim SS, Abbafati C et al (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
doi: 10.1016/S0140-6736(20)30925-9
Coxson HO, Leipsic J, Parraga G, Sin DD (2014) Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 190:135–144. https://doi.org/10.1164/rccm.201402-0256PP
doi: 10.1164/rccm.201402-0256PP
pubmed: 24873985
Jones PW (2009) Health status and the spiral of decline. COPD 6:59–63. https://doi.org/10.1080/15412550802587943
doi: 10.1080/15412550802587943
pubmed: 19229709
Grenier PA, Beigelman-Aubry C, Fetita CI, Brillet P-Y (2009) CT imaging of chronic obstructive pulmonary disease: role in phenotyping and interventions. Expert Opin Med Diagn 3:689–703. https://doi.org/10.1517/17530050903117264
doi: 10.1517/17530050903117264
pubmed: 23496051
Han MK, Agusti A, Calverley PM et al (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598–604. https://doi.org/10.1164/rccm.200912-1843CC
doi: 10.1164/rccm.200912-1843CC
pubmed: 20522794
pmcid: 6850732
Litmanovich DE, Hartwick K, Silva M, Bankier AA (2014) Multidetector computed tomographic imaging in chronic obstructive pulmonary disease: emphysema and airways assessment. Radiol Clin North Am 52:137–154. https://doi.org/10.1016/j.rcl.2013.09.002
doi: 10.1016/j.rcl.2013.09.002
pubmed: 24267715
Lynch DA, Austin JHM, Hogg JC et al (2015) CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology 277:192–205. https://doi.org/10.1148/radiol.2015141579
doi: 10.1148/radiol.2015141579
pubmed: 25961632
Hernández Vázquez J, Ali García I, Jiménez-García R et al (2018) COPD phenotypes: differences in survival. Int J Chron Obstruct Pulmon Dis 13:2245–2251. https://doi.org/10.2147/COPD.S166163
doi: 10.2147/COPD.S166163
pubmed: 30050297
pmcid: 6055897
Coxson HO (2008) Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 5:940–945. https://doi.org/10.1513/pats.200806-057QC
doi: 10.1513/pats.200806-057QC
pubmed: 19056721
pmcid: 2720108
Vestbo J, Anderson W, Coxson HO et al (2008) Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 31:869–873. https://doi.org/10.1183/09031936.00111707
doi: 10.1183/09031936.00111707
pubmed: 18216052
Barr CopdgCWGRG, Berkowitz EA, Bigazzi F, et al (2012) A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 9:151–159. https://doi.org/10.3109/15412555.2012.654923
Martinez CH, Chen Y-H, Westgate PM et al (2012) Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax 67:399–406. https://doi.org/10.1136/thoraxjnl-2011-201185
doi: 10.1136/thoraxjnl-2011-201185
pubmed: 22514236
Bryant M, Ley S, Eberhardt R et al (2015) Assessment of the relationship between morphological emphysema phenotype and corresponding pulmonary perfusion pattern on a segmental level. Eur Radiol 25:72–80. https://doi.org/10.1007/s00330-014-3385-5
doi: 10.1007/s00330-014-3385-5
pubmed: 25163898
Jobst BJ, Wielpütz MO, Triphan SMF et al (2015) Morpho-functional 1H-MRI of the lung in COPD: short-term test-retest reliability. PLoS One 10:e0137282. https://doi.org/10.1371/journal.pone.0137282
doi: 10.1371/journal.pone.0137282
pubmed: 26327295
pmcid: 4556659
Wielpütz MO, Eichinger M, Wege S et al (2019) Midterm reproducibility of chest magnetic resonance imaging in adults with clinically stable cystic fibrosis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 200:103–107. https://doi.org/10.1164/rccm.201812-2356LE
doi: 10.1164/rccm.201812-2356LE
pubmed: 30875236
Wielpütz MO, Puderbach M, Kopp-Schneider A et al (2014) Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med 189:956–965. https://doi.org/10.1164/rccm.201309-1659OC
doi: 10.1164/rccm.201309-1659OC
pubmed: 24564281
Stahl M, Wielpütz MO, Graeber SY et al (2017) Comparison of lung clearance index and magnetic resonance imaging for assessment of lung disease in children with cystic fibrosis. Am J Respir Crit Care Med 195:349–359. https://doi.org/10.1164/rccm.201604-0893OC
doi: 10.1164/rccm.201604-0893OC
pubmed: 27575911
Wucherpfennig L, Triphan SMF, Wege S et al (2022) Magnetic resonance imaging detects improvements of pulmonary and paranasal sinus abnormalities in response to elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis. J Cyst Fibros 21:1053–1060. https://doi.org/10.1016/j.jcf.2022.03.011
doi: 10.1016/j.jcf.2022.03.011
pubmed: 35400600
Woods JC, Wild JM, Wielpütz MO et al (2020) Current state of the art MRI for the longitudinal assessment of cystic fibrosis. J Magnetic Resonan Imaging 52:1306–1320. https://doi.org/10.1002/jmri.27030
doi: 10.1002/jmri.27030
Eichinger M, Optazaite D-E, Kopp-Schneider A et al (2012) Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol 81:1321–1329. https://doi.org/10.1016/j.ejrad.2011.02.045
doi: 10.1016/j.ejrad.2011.02.045
pubmed: 21429685
Wielpütz MO, von Stackelberg O, Stahl M et al (2018) Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. J Cyst Fibros 17:518–527. https://doi.org/10.1016/j.jcf.2018.05.003
doi: 10.1016/j.jcf.2018.05.003
pubmed: 29805050
Karch A, Vogelmeier C, Welte T et al (2016) The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. Respir Med 114:27–37. https://doi.org/10.1016/j.rmed.2016.03.008
doi: 10.1016/j.rmed.2016.03.008
pubmed: 27109808
Jörres RA, Welte T, Bals R et al (2010) Systemic manifestations and comorbidities in patients with chronic obstructive pulmonary disease (COPD) and their effect on clinical state and course of the disease–an overview of the cohort study COSYCONET. Dtsch Med Wochenschr 135:446–449. https://doi.org/10.1055/s-0030-1249185
doi: 10.1055/s-0030-1249185
pubmed: 20198540
International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. (2001) ICH harmonized tripartite guideline: Guideline for Good Clinical Practice. J Postgrad Med 47:45–50
(1997) World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277:925–926
Schiwek M, Triphan SMF, Biederer J et al (2022) Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function. Eur Radiol 32:1879–1890. https://doi.org/10.1007/s00330-021-08229-6
doi: 10.1007/s00330-021-08229-6
pubmed: 34553255
Eichinger M, Puderbach M, Fink C et al (2006) Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis–initial results. Eur Radiol 16:2147–2152. https://doi.org/10.1007/s00330-006-0257-7
doi: 10.1007/s00330-006-0257-7
pubmed: 16673092
Korosec FR, Frayne R, Grist TM, Mistretta CA (1996) Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36:345–351. https://doi.org/10.1002/mrm.1910360304
doi: 10.1002/mrm.1910360304
pubmed: 8875403
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
doi: 10.2307/2529310
pubmed: 843571
Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Harris PA, Taylor R, Minor BL et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https://doi.org/10.1016/j.jbi.2019.103208
doi: 10.1016/j.jbi.2019.103208
pubmed: 31078660
pmcid: 7254481
Biederer J, Reuter M, Both M et al (2002) Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering. Eur Radiol 12(378–84):11870438
Biederer J (2023) MR imaging of the airways. Br J Radiol 20220630. https://doi.org/10.1259/bjr.20220630
Milne S, King GG (2014) Advanced imaging in COPD: insights into pulmonary pathophysiology. J Thoracic Disease 6. https://doi.org/10.3978/j.issn.2072-1439.2014.11.30
Widell J, Lidén M (2020) Interobserver variability in high-resolution CT of the lungs. Eur J Radiol Open 7:100228. https://doi.org/10.1016/j.ejro.2020.100228
doi: 10.1016/j.ejro.2020.100228
pubmed: 32258248
pmcid: 7115039
Ziegler-Heitbrock L, Frankenberger M, Heimbeck I et al (2012) The EvA study: aims and strategy. Eur Respir J 40:823–829. https://doi.org/10.1183/09031936.00142811
doi: 10.1183/09031936.00142811
pubmed: 22441733
Regan EA, Hokanson JE, Murphy JR et al (2010) Genetic epidemiology of COPD (COPDGene) study design. COPD 7:32–43. https://doi.org/10.3109/15412550903499522
doi: 10.3109/15412550903499522
pubmed: 20214461
Triphan SMF, Biederer J, Burmester K et al (2018) Design and application of an MR reference phantom for multicentre lung imaging trials. PLoS One 13:e0199148. https://doi.org/10.1371/journal.pone.0199148
doi: 10.1371/journal.pone.0199148
pubmed: 29975714
pmcid: 6033396
Rampinelli C, De Marco P, Origgi D et al (2017) Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ 356:j347. https://doi.org/10.1136/bmj.j347
doi: 10.1136/bmj.j347
pubmed: 28179230
pmcid: 5421449
Wang Z, Li Y, Lin J et al (2023) Prevalence, risk factors, and mortality of COPD in young people in the USA: results from a population-based retrospective cohort. BMJ Open Respir Res 10:e001550. https://doi.org/10.1136/bmjresp-2022-001550
doi: 10.1136/bmjresp-2022-001550
pubmed: 37451700
pmcid: 10351298
Ohno Y, Hanamatsu S, Obama Y et al (2022) Overview of MRI for pulmonary functional imaging. Br J Radiol 95:20201053. https://doi.org/10.1259/bjr.20201053
doi: 10.1259/bjr.20201053
pubmed: 33529053
Kanda T, Ishii K, Kawaguchi H et al (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841. https://doi.org/10.1148/radiol.13131669
doi: 10.1148/radiol.13131669
pubmed: 24475844
van der Molen AJ, Quattrocchi CC, Mallio CA et al (2023) Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward. Eur Radiol. https://doi.org/10.1007/s00330-023-10281-3
doi: 10.1007/s00330-023-10281-3
pubmed: 38092951
pmcid: 10791953
Triphan SMF, Bauman G, Konietzke P et al (2023) Magnetic resonance imaging of lung perfusion. J Magn Reson Imaging. https://doi.org/10.1002/jmri.28912
doi: 10.1002/jmri.28912
pubmed: 37466278
Li Q, Zhu L, von Stackelberg O et al (2023) MRI compared with low-dose CT for incidental lung nodule detection in COPD: a multicenter trial. Radiol Cardiothorac Imaging 5:e220176. https://doi.org/10.1148/ryct.220176
doi: 10.1148/ryct.220176
pubmed: 37124637
pmcid: 10141334